medigraphic.com

2007, Number 3

<< Back

Rev Med Inst Mex Seguro Soc 2007; 45 (3)

Economic Studies and Decision Analysis as Tools for Decision Making

Rodríguez-Pimentel L, Silva-Romo R, Wacher-Rodarte N

Language: Spanish
References: 17
Page: 297-304
PDF size: 138.41 Kb.


ABSTRACT

Management implies decision-making and economics deals with efficiency which means to obtain the best possible results with the available resources, and to compare such results with those that were foreseen. The economic evaluation comprises a set of techniques aimed at comparing resource allocation on alternate courses of action and its consequences. In health care, these results are the overall well-being of the society. This paper summarizes the techniques that are customarily used in economic evaluation, and intends to serve as an introductory text to increasing the ability of the readers to grasp original articles in the field of health economics.


REFERENCES

  1. Gisbert IGR. Economía y salud. Economía, gestión económica y evaluación económica en el ámbito sanitario. Barcelona, España: Masson; 2002.

  2. Drummond M, Stoddart G, Torrance G. Métodos para la evaluación económica de los programas de atención de la salud. Madrid: Díaz de Santos; 1991.

  3. Gold M, Siegel J, Russell L, Weinstein M. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.

  4. Villarreal-Ríos E, Montalvo-Almaguer G, Salinas-Martínez A, Guzmán-Padilla JE, Tovar-Castillo NH, Garza-Elizondo ME. Costo en el primer nivel de atención. Salud Publica Mex 1996;38: 332-340.

  5. Salinas EG, Martínez VS, Mould QJ, García TIM, Viniegra OA, Durán AL, et al. Informe técnico para la estimación de costos de intervenciones médicas en el Instituto Mexicano del Seguro Social (IMSS). Grupo de Trabajo para la Propuesta de Prestaciones Médicas de Transferencia de Costos Institucionales. IMSS Octubre 2005. Disponible en http://www.imss.gob.mx./IMSS_SITIOS/DPM/informacion/Tecnologia/Principal/htm.

  6. Koopmanschap MA, Van Ineveld BM. Towards a new approach for estimating indirect cost of disease. Soc Sci Med 1992;34:1005:1010.

  7. Lenert L, Kaplan R. Validity and interpretation of preference-based measures of health-related quality of life. Med Care 2000;38(Suppl II):II-138-II-150.

  8. Fenny D. Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 system. Med Care 2002;40:113-128.

  9. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35(11):1095-1108.

  10. Petitti DB. Meta-analysis, decision analysis, and cost-effectiveness analysis. Methods for quantitative synthesis in medicine. 2nd edition. New York: Oxford University Press; 2000.

  11. Briggs A, Sculpher M. Commentary: Markov models of medical prognosis. BMJ 1997;314: 354-355.

  12. Briggs A, Sculpher M, Dawson J, Fitzpatrick R, Murray D, Malchau H. The use of probabilistic decision models in technology assessment: the case of total hip replacement. Appl Health Econ Health Policy 2004;3:79-89.

  13. Wacher-Rodarte NH. Análisis de decisión. En: Moreno AL, Cano VF, García RH, editores. Epidemiología clínica. Segunda edición. México: Interamericana; 1994. p. 169-187.

  14. Sánchez LA. How to evaluate and interpret outcome studies? Pharmacotherapy 2000;20: 282S-291S.

  15. Panel on Cost-Effectiveness in Health and Medicine. Cost-effectiveness in health and medicine. US: US Department of Health and Human Services, Public Health Service; 1996.

  16. Hoffmann C, Stoykova BA, Nixon J, Glandville JM, Misso K, Drummond MF. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities. Value Health 2002; 5:71-78.

  17. Fayers PM, Machin D. Quality of life. Assessment, analysis and interpretation. Chichester: John Wiley and Son; 2000.




2020     |     www.medigraphic.com